glp-1 medication semaglutide Weight Loss Options FDA Approves Oral Semaglutide: First

Apenas se consumen

Hims & Hers, along with other telehealth companies, announced plans last year to sell compounded GLP-1s for a fraction of the price of the brand name, suddenly directly competing with a brand name pharma company that already had that drug on patent

For brands that have historically relied on indulgence, this raises important questions about how emotional value is created in the future

Long-Term Side Effect Considerations Rare but serious complications like gastroparesis (delayed stomach emptying) or pancreatitis do not spontaneously reverse after stopping semaglutide and require ongoing medical monitoring